Maple syrup urine disease: clinical and biochemical significance of gene analysis
Nobukuni, Y.; Mitsubuchi, H.; Akaboshi, I.; Indo, Y.; Endo, F.; Matsuda, I.
Journal of Inherited Metabolic Disease 14(5): 787-792
1991
ISSN/ISBN: 0141-8955
PMID: 1664011
DOI: 10.1007/bf01799951
Accession: 032247508
PDF emailed within 0-6 h: $19.90
Related References
Dahpy, M.A.; Saleem, T.H.; El-Asheer, O.M.; ELrasoul, A.A.; Abo Elgeit, A.M. 2021: Clinical, Biochemical, Molecular, and Therapeutic Analysis of Maple Syrup Urine Disease in Upper Egypt Journal of Pediatric Genetics 10(2): 116-125László, A.; Nagy, I.; Szücs, L.; Havass, Z.; Sztriha, L.; Svékus, A.; Veres, E. 1992: Biochemical, clinical and genetic analysis of various aminoacidopathies (non-ketotic hyperglycemia, maple syrup urine disease, histidinemia, tyrosinemia) Orvosi Hetilap 133(48): 3075-3080
Indo, Y.; Akaboshi, I.; Nobukuni, Y.; Endo, F.; Matsuda, I. 1988: Maple syrup urine disease: a possible biochemical basis for the clinical heterogeneity Human Genetics 80(1): 6-10
Yunus, Z.M.; Kamaludin, D.A.; Mamat, M.; Choy, Y.S.; Ngu, L. 2012: Clinical and biochemical profiles of maple syrup urine disease in malaysian children Jimd Reports 5: 99-107
Harper, P.A.; Dennis, J.A.; Healy, P.J.; Brown, G.K. 1989: Maple syrup urine disease in calves: a clinical, pathological and biochemical study Australian Veterinary Journal 66(2): 46-49
Poothrikovil, R.P.; Al Thihli, K.; Al Futaisi, A. 2021: EEG Pattern in Neonatal Maple Syrup Urine Disease: Description and Clinical Significance Neurodiagnostic Journal 2021: 1-9
Schulman, J.D.; Lustberg, T.J.; Kennedy, J.L.; Museles, M.; Seegmiller, J.E. 1970: A new variant of maple syrup urine disease (branched chain ketoaciduria). Clinical and biochemical evaluation American Journal of Medicine 49(1): 118-124
Mitsubuchi, H.; Nobukuni, Y.; Hayashida, Y.; Ohta, K.; Indo, Y.; Akaboshi, I.; Endo, F.; Matsuda, I. 1993: Gene analysis of maple syrup urine disease (MSUD) Rinsho Byori. Japanese Journal of Clinical Pathology 41(5): 484-491
Morris, M.D.; Lewis, B.D.; Doolan, P.D.; Harper, H.A. 1961: Clinical and biochemical observations on an apparently nonfatal variant of branched-chain ketoaciduria (maple syrup urine disease) Pediatrics 28: 918-923
Yang, N.; Han, L.; Gu, X.; Ye, J.; Qiu, W.; Zhang, H.; Gong, Z.; Zhang, Y. 2012: Analysis of gene mutations in Chinese patients with maple syrup urine disease Molecular Genetics and Metabolism 106(4): 412-418
Silberman, S.hwartzman, J. 1963: Clinical, biochemical and neuropathological aspects of the maple syrup urine disease. A ketoaciduria of the open chain aminoacids leucine, isoleucine and valine An Fac Med Univ Nac Mayor San Marcos Lima 46(3): 339-365
Silbermanschwartzman, J. 1963: Clinical, Biochemical, and Neuropathologic Aspects of Maple Syrup Urine Disease. a Ketoaciduria of the Open Chain Aminoacids Leucine, Isoleucine and Valine ANALES. Universidad Nacional Mayor de San Marcos. Facultad de Medicina 46: 339-365
Mitsubuchi, H.; Matsuda, I.; Nobukuni, Y.; Heidenreich, R.; Indo, Y.; Endo, F.; Mallee, J.; Segal, S. 1992: Gene analysis of Mennonite maple syrup urine disease kindred using primer-specified restriction map modification Journal of Inherited Metabolic Disease 15(2): 181-187
Li, X.; Yang, Y.; Gao, Q.; Gao, M.; Lv, Y.; Dong, R.; Liu, Y.; Zhang, K.; Gai, Z. 2018: Clinical characteristics and mutation analysis of five Chinese patients with maple syrup urine disease Metabolic Brain Disease 33(3): 741-751
Yang, N.; Han, L.-s.; Ye, J.; Qiu, W.-j.; Zhang, H.-w.; Gao, X.-l.; Wang, Y.; Li, X.-y.; Xu, H.; Gu, X.-f. 2012: Clinical characteristics and analysis of mass spectrometric data in 33 patients with maple syrup urine disease Zhonghua Yi Xue Za Zhi 92(40): 2839-2842